Brands Presented New Dermatological Research in Vienna

Neutrogena, Aveeno, and Regaine shared clinical data at the 35th European Academy of Dermatology and Venereology Congress.

Updated on Sept. 30, 2026 in Nutrition

Brands Presented New Dermatological Research in Vienna

Live Poll

Do you look for science-backed clinical evidence before purchasing new skincare or hair products?

Neutrogena, Aveeno, and Regaine presented 12 scientific data sets at the 35th European Academy of Dermatology and Venereology Congress in Vienna. The studies covered various skin and hair concerns, including acne, oily skin, hyperpigmentation, and alopecia.

Why it matters

This research aims to demonstrate how science-backed ingredients support healthy skin and hair. These studies address common consumer concerns including eczema, UV-related damage, and various skin conditions.

A clinical study found that a sunscreen with 2% trehalose and 2% niacinamide reduced redness by 56% and acne-related hyperpigmentation by 46% over 28 days. Additionally, a survey of 178 clinicians showed 92.7% observed steroid-sparing effects with colloidal oat emollients.

The players

Neutrogena

This is a global skincare brand that develops dermatologically tested products for various skin types and concerns.

Aveeno

This brand specializes in skin and hair care products that often utilize natural ingredients like colloidal oatmeal.

Regaine

This is a brand known for its hair loss treatments, frequently utilizing minoxidil as a primary active ingredient.

European Academy of Dermatology and Venereology

This professional non-profit association is dedicated to the field of dermatology and venereology in Europe.

The details

Researchers conducted a 28-day multi-ethnic study on individuals with acne-prone skin using sunscreen, while others evaluated the use of 5% Minoxidil Topical Foam in men. The results indicated significant improvements in hydration, oiliness, and hair growth across demographic groups.

Timeline

  1. September 30, 2026: The 35th EADV Congress begins in Vienna.

  2. October 3, 2026: The 35th EADV Congress concludes.

The Big Picture

The presentation of these findings at the European Academy of Dermatology and Venereology Congress marks a continued effort by skincare brands to validate consumer products through academic peer-level forums.

These clinical findings suggest that patients struggling with acne or oily skin may find relief through specific topical formulations featuring trehalose and niacinamide. For men experiencing hair thinning, the data highlights the measurable results associated with consistent use of minoxidil foam.

The takeaway

Science-backed ingredients are increasingly proving their value in treating common dermatological conditions like hyperpigmentation and alopecia. Consumers should consult with a healthcare professional to see how these specific active ingredients may fit into their existing treatment regimens.

Further reading

For more information on the latest scientific findings in skin health, visit our Nutrition section.

Live Poll

Do you look for science-backed clinical evidence before purchasing new skincare or hair products?